Exelixis Clinical Site #81

Madrid 28046

0 studies enrolling now · 2 studies all time

What they study most

Castration-resistant Prostate Cancer, Colorectal Cancer, Differentiated Thyroid Cancer, Endometrial Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Hepatocellular Carcinoma, Hormone Receptor Positive Breast Carcinoma, Lower Esophageal Cancer, Metastatic Castration-resistant Prostate Cancer, Neoplasm Malignant

Studies at this site

• Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors — Running, not enrolling
• A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors — Running, not enrolling